Accelerate Diagnostics News Today

Oracle Investment Management Inc. lowered its position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Free Report) by 18.3% during the 4th quarter, Holdings Channel reports. The firm owned 111,575 shares of the medical research company’s stock after selling 24,953 shares during the quarter. Accelerate Diagnostics comprises approximately 0.3% of Oracle Investment Management Inc.’s investment portfolio, making […]

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 387,300 shares, an increase of 19.9% from the April 30th total of 322,900 shares. Currently, 2.8% of the company’s stock are sold short. […]

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 387,300 shares, a growth of 19.9% from the April 30th total of 322,900 shares. Based on an average daily volume of 73,300 shares, the days-to-cover ratio […]

StockNews.com began coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a research note released on Wednesday morning. The brokerage issued a hold rating on the medical research company’s stock. A number of other brokerages have also commented on AXDX. William Blair reiterated an outperform rating on shares of Accelerate Diagnostics in a […]

Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, May 8th. Analysts expect Accelerate Diagnostics to post earnings of ($0.72) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Accelerate Diagnostics (NASDAQ:AXDX […]

TUCSON, Ariz., May 2, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review...

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. ...

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 373,700 shares, an increase of 27.7% from the March 31st total of 292,600 shares. Based on an average daily volume of 86,400 shares, the days-to-cover ratio […]

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 26,545 shares of the business’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $0.86, for a total value of $22,828.70. Following the completion of the sale, the chief executive officer now owns 129,726 shares […]

Accelerate Diagnostics Announces 510 Submission of the Accelerate Arc™ System to the FDA Apr 09, 2024 Enabling rapid, automated microbial identification...